Currents in Contemporary Ethics

Author:

Anderlik Mary R.,Elster Nanette

Abstract

Pressure is mounting to hold researchers and research institutions accountable for the protection of human subjects. When subjects or their family members believe they have been injured, they are increasingly willing to file lawsuits. Recent cases indicate that institutional review boards (IREs) and their members may be pulled more and more into the legal fray.On September 17, 1999, 18-year-old Jesse Gelsinger died while participating in research conducted by the University of Pennsylvania's Institute for Gene Therapy. Gelsinger was involved in a Phase I clinical trial testing a new approach to treatment of ornithine transcarbamylase deficiency (OTC), a rare metabolic disorder. Although infants affected by the severe form of OTC die shortly after birth, Gelsinger suffered from a relatively mild form. It appears undisputed that the cause of Gelsinger's death was not the disorder itself, but multiple organ system failure triggered by the virus used to carry new genetic material into his system.

Publisher

Cambridge University Press (CUP)

Subject

Health Policy,General Medicine,Issues, ethics and legal aspects

Reference75 articles.

1. 23. E.g., “I know that we are not constituted to review substantive research issues, but we should be sure that such a review has taken place. … In terms of the consent form, I think if the purpose of the Human Subjects Review Committee is to actually make sure the patient is fully informed, it should include in the consent the risk of GVHD [graft-versus-host disease] in the patients.” Minutes of the Fred Hutchinson Cancer Research Center, Human Subjects Review Committee (January 20, 1981) (on file with authors).

2. 25. Letter from R.W. Day to K.K. Mittal (Oct. 18, 1993), available at .

3. 14. Robertson v. McGee, No. 01CV00G0H(M) (N.D. Okla. filed January 29, 2001), available at , at 2.

4. “Gene Therapy Safety Issues Come to Fore,”;Fox;Nature Biotechnology,1999

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3